Brandon Adler, MD
Dermatology · Los Angeles, CANPI 1992199251
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $950 of the $1,475 with a category attached, or 64.4%. 9 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2021 at $735 and has fallen 97.7% since, to $17 in 2025. That places this record below the midpoint for dermatology clinicians in CA, where the typical reported total is $1,655.
Across 28 payments — averaging $52.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$451
- Sanofi$350
- Eli Lilly$175
- Boehringer Ingelheim$125
- E.r. Squibb & Sons, L.L.C.$125
- Novartis$118
- plus $132 from 3 others
Across 268 payments — averaging $1012.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$170K
- Dermavant Sciences, Inc.$101K
What the payments were for
- Consulting fees$17512%
- Speaking & faculty fees$35024%
- Food & beverage$95064%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 19 | $451 |
| Sanofi | 1 | $350 |
| Eli Lilly | 1 | $175 |
| Boehringer Ingelheim | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $125 |
| Novartis | 2 | $118 |
| Pfizer | 1 | $99 |
| Galderma Laboratories, L.p. | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,475 in reported general payments places this provider in the 45th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 18 | $81,881 |
| Dupixent SyringeDupilumab | 12 | $51,603 |
| Fluocinolone Acetonide | 20 | $1,507 |
| Clobetasol Propionate | 13 | $1,500 |
| Tacrolimus | 16 | $1,329 |
| Ketoconazole | 63 | $684 |
| Fluocinonide | 13 | $534 |
| Gabapentin | 22 | $369 |
| Triamcinolone Acetonide | 39 | $332 |
| Prednisone | 13 | $189 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 11 | $186 |
| Duloxetine Hcl | 11 | $133 |
| Mupirocin | 11 | $72 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Los Angeles
- April ArmstrongLos Angeles$2.3M
- Jennifer HsiaoLos Angeles$746K
- Christopher HoLos Angeles$731K
- Howard SofenLos Angeles$345K
- Nada ElbulukLos Angeles$297K
- Derek JonesLos Angeles$272K
- Pearl GrimesLos Angeles$256K
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.